5439982025-04-012025-06-305439982025-04-012025-06-30in-capmkt:OtherExpenses1Memberiso4217:INRiso4217:INRxbrli:shares543998VALIANTLABNOTLISTEDINE0JWS01017Valiant Laboratories LimitedMain BoardEquity2025-04-012026-03-312025-08-082025-08-05INRLakhsQuarterlyFirst quarterSingle segmentManufacturing of Chemicals2025-08-0814:00:002025-08-0816:05:00Not applicablefalsefalseThe Company hasn't Defaulted on any of its Loan and Debt Securities.2025-04-012025-06-30AuditedStandalone510073000671300051678600039692100047004000-4409000119010007330005141000350370004923280002445800002445800058450004560006301000018157000000018157000018157000434500000100.420.42000.420.421. The above results for the Quarter ended 30th June, 2025 have been reviewed by the Audit Committee in their meeting held on 08th Aug, 2025 and approved by the Board of Directors in their meeting held on 08th Aug, 2025. <BR> <BR> 2. The Company is operating as a single segment company, engaged in manufacturing of chemicals business, and hence there is no separate reportable business segment. <BR> <BR> 3. The aforesaid Audited Financial results will be uploaded on the company's website www.valiantlabs.in and will also be available on the websites of BSE Limited i.e. www.bseindia.com and NSE Limited i.e www.nseindia.com. <BR> <BR> 4. Figures for the previous period have been regrouped or rearranged wherever necessary.Other Expenses35037000